Samsung Biologics announced on Feb. 13 that it has been awarded the Leadership A- grade in the climate change response category by global sustainability evaluation organization Carbon Disclosure Project (CDP). CDP, a non-profit international organization founded in the U.K. in 2000, conducts project
Pharmaceutical companies are expanding their presence into Southeast Asia, particularly Indonesia and Vietnam. There is a high preference for Korean products and a high growth potential in these markets, leading to strong optimism about the possibility of expansion. Among these countries, Indonesia
Samsung Biologics has announced a collaboration with LegoChem Biosciences for the development of Antibody-Drug Conjugate (ADC) therapeutics.On Feb.7, Samsung Biologics revealed it had entered into a new Contract Development Organization (CDO) agreement with LegoChem Biosciences (hereinafter referred
The Ministry of Trade, Industry and Energy (MOTIE) has set a target of US$700 billion for South Korea’s exports next year, with a plan to attract US$35 billion in foreign direct investment in Korea and US$150 trillion in private investment.MOTIE Minister Ahn Duk-geun said in a briefing at the Sejong
비지니스코리아 Jung Min-hee (pr@businesskorea.co.kr)Lotte Group Chairman Shin Dong-bin has expressed his commitment to focusing on nurturing new business ventures while also considering the possibility of selling underperforming businesses. Regarding the management dispute, he stated, “It has been resolved
The Ministry of SMEs and Startups (MSS) is actively moving forward with the designation of new global innovation districts this year. Simultaneously, it is focusing its efforts on strengthening global collaboration programs to foster the venture ecosystem. The ministry plans to strengthen support fo
The Ministry of Trade, Industry, and Energy (MOTIE) and the Korea Trade-Investment Promotion Agency (KOTRA) announced on Jan. 28 that they have published the “JP Morgan Healthcare Conference Weekly Expedition Report” as part of their “Overseas Exhibition Information Provision” series.The 42nd JP Mor
Kang Stem Biotech announced on Jan. 24 that it received final approval from the Japanese Ministry of Health, Labour and Welfare on Jan. 23 for its application for recognition of the manufacture of specific cell processed products.Through this approval, the company will receive adipose tissue from pa
Celltrion announced on Jan. 24 that it has signed a memorandum of understanding with WuXi XDC, a China-based company specialized in Antibody-Drug Conjugates (ADC), for the development of new ADC therapeutics, and has commenced product development for Contract Development and Manufacturing Organizati
Samsung Biologics has made history by becoming the first in the domestic pharmaceutical and biotech industry to surpass 1 trillion won in annual operating profit. Following the achievement of 3 trillion won in annual sales in 2022 and surpassing 1 trillion won in quarterly sales in the third quarter
South Korea’s six major high-tech strategic industries have seen their shares in export markets plummet, losing ground to rival countries. The six strategic industries include semiconductors, displays, secondary batteries, future vehicles, biotech, and robotics.The six industries’ exports in 2022 wa
The government is restructuring industrial and energy technology development projects to focus on high-risk, next-generation, and large-scale tasks. There will be a significant reduction in the financial burden on companies. The plan is to transition to a demand-driven process where businesses and r
Orion is taking its first step into the next-generation anti-cancer drug market by acquiring LegoChem Bio for about 55 billion won.Orion Holdings acquired a 25 percent stake in LegoChem Bio and became the largest shareholder on Jan. 15, according to industry sources on Jan. 16. Orion acquired a tota
During a press conference at the JP Morgan Healthcare Conference (JPMHC), the world’s largest pharmaceutical and biotech investment event, on Jan. 10 (local time), Celltrion Group Chairman Seo Jung-jin announced that the company plans to establish a healthcare investment fund worth 100 trillion won.
According to the BioEconomy Research Center of the Korea Biotechnology Industry Organization on Jan. 10, WuXi Biologics, a leading Chinese biopharmaceutical Contract Development and Manufacturing Organization (CDMO), is confirmed to be constructing a commercial biopharmaceutical raw material product
Chong Kun Dang Pharmaceutical, a leading biotechnological and pharmaceutical company in South Korea, is poised to achieve a nearly sevenfold increase in operating profit in the fourth quarter of last year compared to the same period the previous year. This remarkable growth is attributed to the tech
The Incheon Free Economic Zone Authority announced that Yoo Jeong-bok, mayor of Incheon Metropolitan City, participated in the Consumer Electronics Show 2024 being held from Jan. 9 to 12.At this year’s CES 2024, Incheon is operating a 132.23 square meter pavilion in the North Hall of the Las Vegas C
Samsung C&T Corporation, along with its subsidiaries Samsung Biologics and Samsung Bioepis, announced on Jan. 9 the signing of a memorandum of understanding (MOU) for strategic cooperation with the U.S.-based Flagship Pioneering through their jointly established Life Science Fund No. 2 (SVIC 64th Ne
In 2023, foreign direct investment (FDI) in Korea exceeded US$32.7 billion, a record high. High-tech materials, parts, and equipment such as semiconductors, secondary batteries, and biotech items led the increase in FDI in Korea.According to the Ministry of Trade, Industry and Energy on Jan. 4, FDI
The 42nd JP Morgan Healthcare Conference is set to take place from Jan. 8 to 11 in San Francisco, California, in the U.S. This annual event, held every January, is renowned as the world’s largest healthcare investment venue where major global pharmaceutical companies, emerging biotech firms, and pro